{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:29:30Z","timestamp":1790166570516,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/infdis\/jix030","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T08:23:26Z","timestamp":1485764606000},"page":"525-533","source":"Crossref","is-referenced-by-count":35,"title":["Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis"],"prefix":"10.1093","volume":"216","author":[{"given":"Simon","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Lanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dessislava","family":"Marinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"key":"key\n\t\t\t\t20170913035417_CIT0001","author":"WHO","year":"2016"},{"key":"key\n\t\t\t\t20170913035417_CIT0002","year":"2015"},{"key":"key\n\t\t\t\t20170913035417_CIT0003","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170913035417_CIT0004","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170913035417_CIT0005","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","year":"2008","journal-title":"J R Soc Interface"},{"key":"key\n\t\t\t\t20170913035417_CIT0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2014.11.026","article-title":"Tuberculosis vaccines\u2013state of the art, and novel approaches to vaccine development","volume":"32","year":"2015","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170913035417_CIT0007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tube.2014.10.004","article-title":"The present and future of tuberculosis vaccinations","volume":"95","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"key\n\t\t\t\t20170913035417_CIT0008","doi-asserted-by":"crossref","first-page":"e106519","DOI":"10.1371\/journal.pone.0106519","article-title":"Revaccination of cattle with bacille Calmette-Gu\u00e9rin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170913035417_CIT0009","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2005.07.103","article-title":"Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations","volume":"24","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tube.2004.11.001","article-title":"An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology","volume":"85","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"key\n\t\t\t\t20170913035417_CIT0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170913035417_CIT0012","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170913035417_CIT0013","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0140-6736(92)90794-4","article-title":"Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170913035417_CIT0014","first-page":"27","article-title":"BCG vaccine. WHO position paper","volume":"79","author":"World Health O","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170913035417_CIT0015","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1016\/j.vaccine.2014.04.084","article-title":"Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults","volume":"32","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0016","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0017","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.5588\/ijtld.12.0569","article-title":"A rational vaccine pipeline for tuberculosis","volume":"16","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170913035417_CIT0018","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm0396-334","article-title":"Auxotrophic vaccines for tuberculosis","volume":"2","year":"1996","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170913035417_CIT0020","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0021","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial","volume":"3","year":"2015","journal-title":"Lancet Respir Med"},{"key":"key\n\t\t\t\t20170913035417_CIT0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2015.10.010","article-title":"MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice","volume":"96","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"key\n\t\t\t\t20170913035417_CIT0023","doi-asserted-by":"crossref","first-page":"e1513","DOI":"10.7717\/peerj.1513","article-title":"On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines","volume":"4","year":"2016","journal-title":"PeerJ"},{"key":"key\n\t\t\t\t20170913035417_CIT0024","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170913035417_CIT0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2672.2000.01020.x","article-title":"The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium","volume":"88","year":"2000","journal-title":"J Appl Microbiol"},{"key":"key\n\t\t\t\t20170913035417_CIT0026","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2672.2011.05069.x","article-title":"Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models","volume":"111","year":"2011","journal-title":"J Appl Microbiol"},{"key":"key\n\t\t\t\t20170913035417_CIT0027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vascn.2003.07.001","article-title":"The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates","volume":"49","year":"2004","journal-title":"J Pharmacol Toxicol Methods"},{"key":"key\n\t\t\t\t20170913035417_CIT0028","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"key\n\t\t\t\t20170913035417_CIT0029","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.vaccine.2015.03.083","article-title":"Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0030","doi-asserted-by":"crossref","first-page":"16302","DOI":"10.1073\/pnas.0808746105","article-title":"Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines","volume":"105","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170913035417_CIT0031","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","year":"2010","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20170913035417_CIT0032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20170913035417_CIT0033","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1016\/j.vaccine.2005.07.106","article-title":"The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research","volume":"23","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0034","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0041-3879(85)90064-9","article-title":"Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence","volume":"66","year":"1985","journal-title":"Tubercle"},{"key":"key\n\t\t\t\t20170913035417_CIT0035","doi-asserted-by":"crossref","first-page":"e113951","DOI":"10.1371\/journal.pone.0113951","article-title":"Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170913035417_CIT0036","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170913035417_CIT0037","first-page":"747","article-title":"BCG-induced allergy and immunity in guinea-pigs during the first year after vaccination","volume":"36","year":"1967","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170913035417_CIT0038","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1016\/j.vaccine.2014.07.113","article-title":"Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG)","volume":"32","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170913035417_CIT0039","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1165\/rcmb.2008-0154TR","article-title":"What animal models teach humans about tuberculosis","volume":"39","year":"2008","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/5\/525\/19887452\/jix030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T03:54:34Z","timestamp":1505274874000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/5\/525\/2949726\/Revaccination-of-Guinea-Pigs-With-the-Live"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,1,25]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix030","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]}}}